Systematic Wide-Field EMR Scar Assessment and Therapy Audit
NCT ID: NCT02617992
Last Updated: 2021-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2013-09-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROSpective Assessment of Post EmR Recurrence
NCT02957058
Upper GI Outcomes Following EMR
NCT02305290
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach
NCT02306707
Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable
NCT06193356
The Australian Colonic Large Sessile Lesion Endoscopic Resection Study
NCT03471793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EMR Surveillance
Patients who are referred for Endoscopic Mucosal Resection of Upper Gastrointestinal Lesions undertaking a surveillance visit will be included in this cohort.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Able to give informed consent to involvement in the clinical study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Sydney Local Health District
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Michael Bourke
Director of Gastrointestinal Endoscopy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Bourke, MBBS
Role: PRINCIPAL_INVESTIGATOR
Western Sydney Local Health District
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westmead Hospital
Westmead, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC2013/8/6.5 (3796)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.